Glycerol with magnesium sulfate and phenol
Brand names: Glycerol BP suppositories
This is a compound rectal enema combining glycerol, magnesium sulfate and phenol, used to relieve constipation and to evacuate the bowel.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Magnesium sulfate and glycerol act as osmotic agents drawing water into the bowel lumen while glycerol also lubricates, together promoting rectal evacuation; phenol provides a mild local effect.
Prescribing in practice
- It is contraindicated in acute gastrointestinal conditions such as intestinal obstruction, acute inflammatory bowel disease and undiagnosed abdominal pain or rectal bleeding.
- Magnesium can be absorbed from the bowel, so caution is needed in renal impairment and the elderly where magnesium accumulation may occur.
- It is intended for occasional bowel evacuation rather than long-term management of constipation.
Monitoring
Routine monitoring is not generally required, but consider electrolyte status with repeated use or in renal impairment given the magnesium content.
Counselling the patient
- This enema is given to clear the lower bowel and usually works within a short time.
- Tell the team if you have kidney problems or significant abdominal pain before it is used.
Evidence & guidelines
Compound osmotic rectal enemas are an established option for bowel evacuation where a rapid rectal effect is required.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021